Its therapeutic significance is linked to the impairmentof NRAS mutant cancer cell growth, since the antiproliferative effectwas abrogated in cells lacking ABHD17A and ABHD17B, thus confirmingthe ABHD17 inhibition by 69. Here, NRAS is linked to cancer.